Preparation of finasteride capsules-loaded drug nanoparticles: formulation, optimization, in vitro, and pharmacokinetic evaluation

References

• KhadkaPRoJKimHPharmaceutical particle technologies: an approach to improve drug solubility, dissolution and bioavailabilityAsian J Pharm Sci20149630431610.1016/j.ajps.2014.05.005
   Google Scholar
• Badr-EldinSMAhmedTAIsmailHRAripiprazole-cyclodextrin binary systems for dissolution enhancement: effect of preparation technique, cyclodextrin type and molar ratioIran J Basic Med Sci201316121223123124570827
   PubMed Web of Science ®Google Scholar
• ShidRLDholeSNKulkarniNShidSLNanosuspension: a reviewInt J Pharm Sci Rev Res201322198106
   Google Scholar
• KumarGPKrishnaKGNanosuspensions: the solution to deliver hydrophobic drugsInt J Drug Deliv20113454655710.5138/385
   Google Scholar
• AhmedTAPreparation of transfersomes encapsulating sildenafil aimed for transdermal drug delivery: Plackett–Burman design and characterizationJ Liposome Res201525111010.3109/08982104.2014.95027625148294
   PubMed Web of Science ®Google Scholar
• El-SayKMAhmedTABadr-EldinSMFahmyUAldawsariHAhmedOAAEnhanced permeation parameters of optimized nanostructured simvastatin transdermal films: ex vivo and in vivo evaluationPharm Dev Technol201520891992610.3109/10837450.2014.938859
   PubMed Web of Science ®Google Scholar
• AhmedOAABadr-EldinSMTawfikMKAhmedTAEl-SayKMBadrJMDesign and optimization of self-nanoemulsifying delivery system to enhance quercetin hepatoprotective activity in paracetamol- induced hepatotoxicityJ Pharm Sci2014103260261210.1002/jps.2383424395640
   PubMed Web of Science ®Google Scholar
• Al-SubaieMMHosnyKMMohamed El-SayKAhmedTAAljaeidBMUtilization of nanotechnology to enhance percutaneous absorption of acyclovir in the treatment of herpes simplex viral infectionsInt J Nanomedicine2015103973398510.2147/IJN.S8396226109856
   PubMed Web of Science ®Google Scholar
• SutradharKBKhatunSLunaIPIncreasing possibilities of nanosuspensionJ Nanotechnol2013201311210.1155/2013/346581
   Google Scholar
• LiWYangYTianYPreparation and in vitro/in vivo evaluation of revaprazan hydrochloride nanosuspensionInt J Pharm20114081–215716210.1016/j.ijpharm.2011.01.05921295124
   PubMed Web of Science ®Google Scholar
• JacobsCKayserOMüllerRHProduction and characterisation of mucoadhesive nanosuspensions for the formulation of bupravaquoneInt J Pharm20012141–23711282227
   PubMed Web of Science ®Google Scholar
• PatravaleVBDateAAKulkarniRMNanosuspensions: a promising drug delivery strategyJ Pharm Pharmacol200456782784010.1211/002235702369115233860
   PubMed Web of Science ®Google Scholar
• KeckCMMüllerRHDrug nanocrystals of poorly soluble drugs produced by high pressure homogenisationEur J Pharm Biopharm200662131610.1016/j.ejpb.2005.05.00916129588
   PubMed Web of Science ®Google Scholar
• FallerBFarleyDNickHFinasteride: a slow-binding 5 alpha-reductase inhibitorBiochemistry19933221570557108389191
   PubMed Web of Science ®Google Scholar
• SteinerJFClinical pharmacokinetics and pharmacodynamics of finasterideClin Pharmacokinet199630116278846625
   PubMed Web of Science ®Google Scholar
• PrahaladaSRKeenanKPHertzogPRQualitative and quantitative evaluation of prostatic histomorphology in rats following chronic treatment with finasteride, a 5-alpha reductase inhibitorUrology19944356806857513109
   PubMed Web of Science ®Google Scholar
• WangYLiuZZhangDDevelopment and in vitro evaluation of deacety mycoepoxydiene nanosuspensionColloids Surf B Biointerfaces201183218919710.1016/j.colsurfb.2010.10.02921176876
   PubMed Web of Science ®Google Scholar
• IbrahimHMAhmedTAHussainMDDevelopment of meloxicam in situ implant formulation by quality by design principleDrug Dev Ind Pharm201390451810.3109/03639045.2012.746360
   Web of Science ®Google Scholar
• US Food Drug AdministrationBioequivalence Studies with Pharmacokinetic Endpoints for Drugs Submitted Under an ANDAUS Department of Health and Human ServicesRockville, MD, USA2013 Available from: http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm377465.pdf
   Google Scholar
• AnutraKKumsornBRojanasthienNBioequivalence study of generic finasteride in healthy male volunteersChiang Mai Med Bull2003424131137
   Google Scholar
• WangYZhengYZhangLWangQZhangDStability of nanosuspensions in drug deliveryJ Control Release201317231126114110.1016/j.jconrel.2013.08.00623954372
   PubMed Web of Science ®Google Scholar
• SahuBPDasMKOptimization of felodipine nanosuspensions using full factorial designInt J PharmTech Res201352553561
   Google Scholar
• El-BadryMFetihGSalem-BekhitMMShakeelFFormulation and evaluation of nanosuspension of albendazole for dissolution enhancementNanosci Nanotechnol Lett2013591024102910.1166/nnl.2013.1645
   Google Scholar
• PandyaVMPatelJKPatelDJFormulation and optimization of nanosuspensions for enhancing simvastatin dissolution using central composite designDissolut Technol2011184045
   Web of Science ®Google Scholar
• EsfandiERamezaniVVatanaraARouholamini NajafabadiAHadipour MoghaddamSPClarithromycin dissolution enhancement by preparation of aqueous nanosuspensions using sonoprecipitation techniqueIran J Pharm Res201413380981825276181
   PubMed Web of Science ®Google Scholar
• MishraBAryaNTiwariSInvestigation of formulation variables affecting the properties of lamotrigine nanosuspension using fractional factorial designDaru20101811822615586
   PubMed Web of Science ®Google Scholar
• WiśniewskaMThe temperature effect on electrokinetic properties of the silica-polyvinyl alcohol (PVA) systemColloid Polym Sci2011289334134410.1007/s00396-010-2341-421472022
   PubMed Web of Science ®Google Scholar
• QuanPShiKPiaoHA novel surface modified nitrendipine nanocrystals with enhancement of bioavailability and stabilityInt J Pharm20124301–236637110.1016/j.ijpharm.2012.04.02522531846
   PubMedGoogle Scholar
• ThakkarHPPatelBVThakkarSPDevelopment and characterization of nanosuspensions of olmesartan medoxomil for bioavail-ability enhancementJ Pharm Bioallied Sci20113342643410.4103/0975-7406.8445921966165
   PubMedGoogle Scholar
• ItoTSunLBevanMACrooksRMComparison of nanoparticle size and electrophoretic mobility measurements using a carbon-nanotube-based coulter counter, dynamic light scattering, transmission electron microscopy, and phase analysis light scatteringLangmuir200420166940694510.1021/la049524t15274607
   PubMed Web of Science ®Google Scholar
• BrownMEIntroduction to Thermal Analysis: Techniques and ApplicationsBerlin, GermanySpringer Science & Business Media2001
   Google Scholar
• NagalaxmiVMahipal ReddyLManikanta KumarAManjunath ShettyKSFormulation and evaluation of controlled release matrix tablets of finasterideInt J Pharm Dev Technol2014416370
   Google Scholar
• KurakulaMAhmedTACo-delivery of atorvastatin nanocrystals in PLGA based in situ gel for anti-hyperlipidemic efficacyCurr Drug Deliv201613111
   Web of Science ®Google Scholar
• GaoYQianSZhangJPhysicochemical and pharmacokinetic characterization of a spray-dried cefpodoxime proxetil nanosuspensionChem Pharm Bull (Tokyo)201058791291720606336
   PubMed Web of Science ®Google Scholar
• LeeJDrug nano- and microparticles processed into solid dosage forms: physical propertiesJ Pharm Sci200392102057206810.1002/jps.1047114502544
   PubMed Web of Science ®Google Scholar
• SahuBPDasMKNanosuspension for enhancement of oral bioavail-ability of felodipineAppl Nanosci20134218919710.1007/s13204-012-0188-3
   Web of Science ®Google Scholar
• MariaOSantosMLauraASantosAPereiraGRBonfilioRA dissolution test for finasteride in immediate-release capsulesDissolution Technol20132032533
   Web of Science ®Google Scholar
• El-SayKMEl-HelwA-RMAhmedOAStatistical optimization of controlled release microspheres containing cetirizine hydrochloride as a model for water soluble drugsPharm Dev Technol201520673874610.3109/10837450.2014.92035324856961
   PubMed Web of Science ®Google Scholar
• AhmedTAEl-SayKMMahmoudMFSamyAMBadawiAAMiconazole nitrate oral disintegrating tablets: in vivo performance and stability studyAAPS PharmSciTech201213376077110.1208/s12249-012-9798-z22585373
   PubMed Web of Science ®Google Scholar
• HuiYHuangNHEbbertLPharmacokinetic comparisons of tail-bleeding with cannula- or retro-orbital bleeding techniques in rats using six marketed drugsJ Pharmacol Toxicol Methods56225626410.1016/j.vascn.2007.05.006.17618130
   PubMedGoogle Scholar